The Sangamo Domain
Vital Information for Sangamo Therapeutics (SGMO) Investors
Friday, October 30, 2015
Lysogene Planning Phase 3 Gene Therapy Trial for SanFilippo A in 2017 ( lysosomal storage disease)
20 minute podcast with the founder of Lysogene (also mother of child with SanFilippo) planning on starting gene therapy PIII in 2017
https://globalgenes.org/raredaily/rarecast-gene-therapy-company-born-from-mothers-quest-to-cure-daughter/
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment